DK0601001T3 - Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. - Google Patents
Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.Info
- Publication number
- DK0601001T3 DK0601001T3 DK92918163.4T DK92918163T DK0601001T3 DK 0601001 T3 DK0601001 T3 DK 0601001T3 DK 92918163 T DK92918163 T DK 92918163T DK 0601001 T3 DK0601001 T3 DK 0601001T3
- Authority
- DK
- Denmark
- Prior art keywords
- guanidinopropionic acid
- pct
- food product
- insulin
- provides
- Prior art date
Links
- KMXXSJLYVJEBHI-UHFFFAOYSA-N 3-guanidinopropanoic acid Chemical compound NC(=[NH2+])NCCC([O-])=O KMXXSJLYVJEBHI-UHFFFAOYSA-N 0.000 title abstract 5
- 235000021056 liquid food Nutrition 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 230000003914 insulin secretion Effects 0.000 abstract 2
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 abstract 2
- 230000001235 sensitizing effect Effects 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- GHUUBYQTCDQWRA-UHFFFAOYSA-N Pioglitazone hydrochloride Chemical compound Cl.N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 GHUUBYQTCDQWRA-UHFFFAOYSA-N 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 229940127003 anti-diabetic drug Drugs 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960004580 glibenclamide Drugs 0.000 abstract 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 abstract 1
- 229960004346 glimepiride Drugs 0.000 abstract 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960005095 pioglitazone Drugs 0.000 abstract 1
- 229960002827 pioglitazone hydrochloride Drugs 0.000 abstract 1
- 230000007103 stamina Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75055991A | 1991-08-26 | 1991-08-26 | |
| US07/751,239 US6008253A (en) | 1991-08-26 | 1991-08-26 | Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0601001T3 true DK0601001T3 (da) | 1997-10-20 |
Family
ID=27115296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92918163.4T DK0601001T3 (da) | 1991-08-26 | 1992-08-19 | Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5900435A (da) |
| EP (1) | EP0601001B1 (da) |
| JP (1) | JPH06510286A (da) |
| AT (1) | ATE151634T1 (da) |
| AU (1) | AU2479492A (da) |
| DE (1) | DE69219136T2 (da) |
| DK (1) | DK0601001T3 (da) |
| ES (1) | ES2101866T3 (da) |
| GR (1) | GR3023848T3 (da) |
| WO (1) | WO1993003724A1 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7316591A (en) * | 1990-02-28 | 1991-09-18 | Upjohn Company, The | Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| AU3117497A (en) * | 1996-05-21 | 1997-12-09 | Pharmacia & Upjohn Company | Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus |
| AU3552697A (en) * | 1996-07-12 | 1998-02-09 | Smithkline Beecham Plc | Novel treatment of leptine resistance |
| ATE399545T1 (de) * | 1996-11-08 | 2008-07-15 | Nippon Chemiphar Co | Mittel zur verringerung der eigeweidefette |
| US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
| AP1279A (en) * | 1997-06-18 | 2004-05-20 | Smithkline Beecham Plc | Treatment of diabetes with thiazolidinedione and metformin. |
| AU8539298A (en) * | 1997-06-18 | 1999-01-04 | Smithkline Beecham Plc | Treatment of diabetes with thiazolidinedione and sulphonylurea |
| US20010049380A1 (en) * | 1997-06-18 | 2001-12-06 | Smith Stephen Alistair | Treatment of diabetes with thiazolidinedione and sulphonylurea |
| US20020004515A1 (en) * | 1997-06-18 | 2002-01-10 | Smith Stephen Alistair | Treatment of diabetes with thiazolidinedione and metformin |
| AU8799998A (en) * | 1997-06-18 | 1999-01-04 | Smithkline Beecham Plc | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
| GB9715298D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| GB9715306D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| US20020016287A1 (en) * | 1997-07-18 | 2002-02-07 | Smithkline Beecham P.L.C. | Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
| GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| ES2255316T3 (es) | 1998-06-30 | 2006-06-16 | Takeda Pharmaceutical Company Limited | Composicion farmaceutica para el tratamiento de diabetes. |
| US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
| GB9824893D0 (en) * | 1998-11-12 | 1999-01-06 | Smithkline Beckman Corp | Novel method of treatment |
| US6667064B2 (en) * | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
| US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US7504118B2 (en) | 2003-04-11 | 2009-03-17 | Fhg Corporation | Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport |
| WO2006101325A1 (en) * | 2005-03-19 | 2006-09-28 | Se Young Chung | A method for preparing extract for the prevention and treatment of hyperlipidemia and obesity from the extract of aster spathulifolius aerial part and composition containing the same |
| WO2012138214A1 (en) * | 2011-04-08 | 2012-10-11 | Brewster Lizzy Maritza | Beta-guanidinopropionic acid for the treatment of hypertension |
| HUE039797T2 (hu) * | 2012-10-18 | 2019-02-28 | Nissin Foods Holdings Co Ltd | Sós ízt fokozó szer és eljárás annak elõállítására, és sós ízt fokozó módszer |
| EP4072561A4 (en) * | 2019-12-11 | 2023-11-29 | Inspirna, Inc. | CANCER TREATMENT METHODS |
| CN113598232A (zh) * | 2021-07-05 | 2021-11-05 | 安徽科技学院 | 一种非发酵凝固型甜酒风味奶及其生产方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1195199A (en) * | 1966-11-25 | 1970-06-17 | Horlicks Pharmaceuticals Ltd | Improvements in Compositions comprising Insulin. |
| GB1195200A (en) * | 1967-02-07 | 1970-06-17 | Horlicks Pharmaceuticals Ltd | Pharmaceutical Compositions. |
| US3843798A (en) * | 1973-03-12 | 1974-10-22 | Stanley Drug Products Inc | Methods and compositions for inducing resistance to bacterial infections |
| GB1552179A (en) * | 1976-11-02 | 1979-09-12 | Beecham Group Ltd | Pharmaceutical compositions for treating hyperglycaemia |
| US5053420A (en) * | 1989-10-13 | 1991-10-01 | Pershadsingh Harrihar A | Thiazolidine derivatives for the treatment of hypertension |
| IT1237519B (it) * | 1989-11-27 | 1993-06-08 | Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina | |
| GB9003185D0 (en) * | 1990-02-13 | 1990-04-11 | Ici Plc | Pharmaceutical compositions |
| AU7316591A (en) * | 1990-02-28 | 1991-09-18 | Upjohn Company, The | Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
-
1992
- 1992-08-19 JP JP5504419A patent/JPH06510286A/ja active Pending
- 1992-08-19 DK DK92918163.4T patent/DK0601001T3/da active
- 1992-08-19 EP EP92918163A patent/EP0601001B1/en not_active Expired - Lifetime
- 1992-08-19 AT AT92918163T patent/ATE151634T1/de not_active IP Right Cessation
- 1992-08-19 DE DE69219136T patent/DE69219136T2/de not_active Expired - Fee Related
- 1992-08-19 AU AU24794/92A patent/AU2479492A/en not_active Abandoned
- 1992-08-19 US US08/196,250 patent/US5900435A/en not_active Expired - Fee Related
- 1992-08-19 WO PCT/US1992/006776 patent/WO1993003724A1/en active IP Right Grant
- 1992-08-19 ES ES92918163T patent/ES2101866T3/es not_active Expired - Lifetime
-
1997
- 1997-06-19 GR GR970401487T patent/GR3023848T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5900435A (en) | 1999-05-04 |
| JPH06510286A (ja) | 1994-11-17 |
| DE69219136T2 (de) | 1997-08-28 |
| EP0601001B1 (en) | 1997-04-16 |
| EP0601001A1 (en) | 1994-06-15 |
| GR3023848T3 (en) | 1997-09-30 |
| ES2101866T3 (es) | 1997-07-16 |
| WO1993003724A1 (en) | 1993-03-04 |
| ATE151634T1 (de) | 1997-05-15 |
| DE69219136D1 (de) | 1997-05-22 |
| AU2479492A (en) | 1993-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0601001T3 (da) | Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. | |
| McElroy et al. | Overview of the treatment of binge eating disorder | |
| GEP20053538B (en) | Pharmaceutical Composition Comprising A Combination of Metformin and Glyburide | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| DZ1794A1 (fr) | Nouvelle formule pharmaceutique. | |
| AU1923088A (en) | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents | |
| HUP0002373A2 (hu) | Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények | |
| CA2073873A1 (en) | Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders | |
| HUT66826A (en) | Human il-4 mutant proteins, thats containing pharmaceutical product and process for producing of proteins | |
| Jordan et al. | Hunger and satiety in humans during parenteral hyperalimentation | |
| McNeil et al. | Domestic metallic mercury poisoning | |
| US3928578A (en) | Composition for control of white muscle disease | |
| ATE143947T1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten | |
| KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
| Ostern et al. | Hypertension following Ornade ingestion | |
| DE69230790T2 (de) | Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen | |
| US4259322A (en) | Method of treatment of tuberculosis | |
| Mirtallo et al. | Albumin in TPN solutions: potential savings from a prospective review | |
| US3565560A (en) | Pharmaceutical preparation containing hydrofuramide and method of using it | |
| JPS6322016A (ja) | 免疫刺激剤 | |
| US3449499A (en) | Method for the reduction of glycemia | |
| US3740440A (en) | Method of inhibiting appetite for food | |
| US2628184A (en) | Composition of matter to decrease the circulation of blood and lymph in vascular and allergic disorders | |
| ASHER | A CLINICAL ASSESSMENT OF ANORECTIC DRUGS | |
| RU2113227C1 (ru) | Способ лечения ожирения |